Why AI and robotics will define New Health

whitePaper | May 16, 2023

The healthcare and life sciences communities have been undergoing a massive digital transformation since the COVID-19 pandemic. Everything from healthcare consumer expectations to government regulations are driving providers, payers, and pharmaceutical organizations to move aggressively toward digital interactions and transactions

whitePaper | August 4, 2022

The pressure to change is coming from all directions. Patients want care to be more personalized and convenient. Employees want the systems that support their work to function better.

whitePaper | December 30, 2022

Every employer needs to provide their employee health plan members with access to providers when the member is away from home or when they need access to a specialist that isn’t available in their primary network.

whitePaper | March 2, 2020

In the decade since the HITECH Act was passed, first-generation electronic health record systems provided a foundation for innovations such as electronic prescribing, clinical decision support and predictive analytics. While usability and productivity issues with EHRs have been well documented, there are significant untapped opportunities to optimize the EHR and health IT. In this whitepaper, PatientKeeper outlines a vision for the future of health IT through the next decade, which includes New data-driven approaches that leverage the clinical information being captured by the EHR to improve patient outcomes and reduce physician burnout, Optimized communication between physicians, nurses and ancillary staff to produce better patient outcomes as efficiencies improve, Better interoperability to improve care coordination and inspire opportunities for ideas like telemedicine to alleviate physician shortages

whitePaper | August 26, 2022

These days, you can’t have a conversation about cybersecurity without talking about zero trust. The security concept requires that all individuals and devices on a network be continuously authenticated, authorized, and monitored.

whitePaper | December 7, 2022

The target market for conducting global clinical trials has changed significantly, moving beyond pharmaceutical early adopters to the mainstream marketplace.